Scotts Miracle-gro CO Form 4 insider transactions

Director Adam Hanft reports the vesting of restricted stock units into common shares of Scotts Miracle-Gro.

Director Peter Shumlin reports the conversion of restricted stock units into common shares of Scotts Miracle-Gro Co.

Director David C. Evans exercised dividend equivalent rights, acquiring 198 common shares of Scotts Miracle-Gro on February 4, 2025.

Director Brian E. Sandoval exercised dividend equivalent rights converting into 150 common shares of Scotts Miracle-Gro on February 4, 2025.

Katherine Hagedorn Littlefield, a director and potential 10% owner of Scotts Miracle-Gro Co., reports changes in her beneficial ownership of common shares and derivative securities.

Director Stephen L. Johnson reports a transaction involving Scotts Miracle-Gro common shares on February 4, 2025.

Dimiter Todorov, EVP, CLO & Corporate Secretary of Scotts Miracle-Gro, reported the disposal of 340 common shares to cover tax obligations.

James Hagedorn, Chairman & CEO of Scotts Miracle-Gro, reports a disposition of shares to cover tax obligations and updates to beneficial ownership.

Christopher Hagedorn, EVP & Chief of Staff at Scotts Miracle-Gro, reports the disposal of 1,951 common shares to cover tax obligations.

Director Adam Hanft reports changes in beneficial ownership of Scotts Miracle-Gro (SMG) common shares due to an acquisition and disposal on January 31, 2025.

Nathan Eric Baxter, President and COO of Scotts Miracle-Gro, acquired 10,749 stock options on January 31, 2025.

Director David C. Evans reports acquiring 3,765 common shares of Scotts Miracle-Gro on January 31, 2025.

Director John R. Vines reports acquisition and disposal of Scotts Miracle-Gro (SMG) common shares on January 31, 2025.

Christopher Hagedorn, EVP & Chief of Staff at Scotts Miracle-Gro, acquired 5,375 stock options on January 31, 2025.

Director Stephen L. Johnson reports acquisition and disposal of Scotts Miracle-Gro (SMG) common shares and deferred stock units.

Director Edith Aviles of Scotts Miracle-Gro Co. reports acquiring 3,765 common shares and disposing of 11,502 common shares on January 31, 2025.

Director Brian E. Sandoval of Scotts Miracle-Gro acquired common shares and deferred stock units on January 31, 2025.

Dimiter Todorov, EVP, CLO & Corporate Secretary at Scotts Miracle-Gro, acquired 1,613 stock options on January 31, 2025.

A Form 4 filing reveals that a director at Scotts Miracle-Gro, Mark D. Kingdon, acquired 3,765 common shares on January 31, 2025.

Mark J. Scheiwer, Interim CFO & CAO of Scotts Miracle-Gro, was granted 7,524 stock options on January 31, 2025.

Director Peter E. Shumlin exercised deferred stock units, converting them into common shares of Scotts Miracle-Gro on January 31, 2025.

Director Nick Miaritis acquired 3,765 common shares of Scotts Miracle-Gro through a non-open market transaction.

Director Roberto Candelino reports acquiring and disposing of common shares of Scotts Miracle-Gro on January 31, 2025.

Scotts Miracle-Gro's Chairman and CEO, James Hagedorn, exercised stock options and sold a portion of his holdings on January 30, 2025.

A Scotts Miracle-Gro executive, Christopher Hagedorn, exercised stock options and sold a portion of his holdings on January 30, 2025.

Christopher Hagedorn, an EVP at Scotts Miracle-Gro, acquired 3,823.1 shares of common stock at a price of $56.76 per share on December 24, 2024.

Mark J. Scheiwer, Interim CFO & CAO of Scotts Miracle-Gro, acquired 6,221 shares of phantom stock on January 27, 2025.

James Hagedorn, CEO of Scotts Miracle-Gro, reported acquiring common shares and phantom stock, while also disposing of some common shares.

Scotts Miracle-Gro CEO James Hagedorn converted phantom stock units into common shares and disposed of some shares to cover tax obligations.

James Hagedorn, CEO and Chairman of Scotts Miracle-Gro, acquired 1,339.542 shares of phantom stock on December 26, 2024.